Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vevye vs Generic Cyclosporine Emulsion in Dry Eye Disease
NCT07368595Phase 4Not yet recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in dry eye disease (DED), sponsored by Baylor College of Medicine. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07368595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07368595.